Sign in

CIK 0001388320 · Non-accelerated filer<br>Smaller reporting company

Actinium Pharmaceuticals, Inc.

Sign in to watch
Ticker
ATNM
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
880378336
Phone
(646) 677-3870
Business address
100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
Former names
Cactus Ventures, Inc.
  1. 424B5 Offering Prospectus
  2. 3 Insider Initial Statement of Ownership
  3. 8-K Event Material agreement · Executive or director change
  4. 4 Open-market buy Chief Medical Officer bought 5,000 shares at $1.11 ($5,550)
  5. 4 Open-market buy Chairman and CEO bought 7,500 shares at an average $1.16 ($8,725)
  6. 4 Open-market buy Principal Financial Officer bought 3,500 shares at $1.17 ($4,095)
  7. 8-K Event Executive or director change
  8. 8-K Event Material agreement
  9. 8-K/A Event Executive or director change
  10. 3 Insider Initial Statement of Ownership
  11. 8-K Event Executive or director change
  12. 10-Q Report Quarterly Report
  13. 8-K Event Material agreement · Executive or director change
  14. NT 10-Q Other NT 10-Q
  15. UPLOAD Other SEC-generated Letter
  16. 3 Insider Initial Statement of Ownership
  17. 8-K Event Executive or director change · Other events
  18. 4 Derivatives Options or other derivatives
  19. S-3 Offering Registration Statement
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 14 of 26 · 511 filings